Subscribe to our Newsletters !!
There is one fact about life on Earth we cannot es
Enter any scientific lab and among the first tools
The Nobel Prize in Physiology or Medicine awarded
Shilpa Medicare – the full-service contract de
Alembic Pharmaceutica
Tofu has been a favorite food for vegetarians and
Dear Readers, Welcome to the latest issue of Micr
Tacrolimus capsule is an immunosuppressant and can be employed for preventing organ rejection in certain patients after kidney, liver, or heart transplant.
Glenmark Pharmaceuticals Inc, USA, has been granted final approval by the United States Food and Drug Administration (USFDA) for Tacrolimus Capsules USP in the strengths of 0.5 mg, 1 mg and 5 mg, Glenmark said in a regulatory filing.
Quoting IQVIA sales data for the 12 months ending September 2020, Glenmark said the Prograf Capsules, 0.5 mg, 1 mg and 5 mg marketplace achieved annual sales of about USD 286.8 million.
Glenmark said current portfolio consists of 166 products authorised for distribution in the US marketplace and 45 abbreviated new drug applications are pending approval together with the USFDA.
Shares of Glenmark Pharma were trading at Rs 479 each scrip on the BSEup 0.94 per cent over the previous close. PTI SVK BAL
